GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,638,000 | +30.9% | 83,590 | +31.0% | 0.05% | +38.2% |
| Q1 2022 | $2,779,000 | +10.3% | 63,799 | +11.6% | 0.03% | +9.7% |
| Q4 2021 | $2,520,000 | +28.3% | 57,142 | +11.2% | 0.03% | +14.8% |
| Q3 2021 | $1,964,000 | +20.3% | 51,406 | +25.4% | 0.03% | +17.4% |
| Q2 2021 | $1,632,000 | +55.7% | 40,993 | +39.6% | 0.02% | +4.5% |
| Q1 2021 | $1,048,000 | +34.2% | 29,366 | +38.3% | 0.02% | +22.2% |
| Q4 2020 | $781,000 | +40.2% | 21,233 | +43.5% | 0.02% | +28.6% |
| Q3 2020 | $557,000 | -29.1% | 14,795 | -23.2% | 0.01% | -33.3% |
| Q2 2020 | $786,000 | +19.1% | 19,261 | +10.5% | 0.02% | -4.5% |
| Q1 2020 | $660,000 | -23.6% | 17,429 | -5.6% | 0.02% | -4.3% |
| Q4 2019 | $864,000 | +18.8% | 18,455 | +8.7% | 0.02% | +4.5% |
| Q3 2019 | $727,000 | +4.2% | 16,973 | -2.7% | 0.02% | +4.8% |
| Q2 2019 | $698,000 | -7.7% | 17,439 | -4.0% | 0.02% | -16.0% |
| Q1 2019 | $756,000 | +21.5% | 18,157 | +11.6% | 0.02% | +4.2% |
| Q4 2018 | $622,000 | -7.4% | 16,263 | -3.0% | 0.02% | +4.3% |
| Q3 2018 | $672,000 | +7.2% | 16,763 | +7.3% | 0.02% | -25.8% |
| Q2 2018 | $627,000 | -13.8% | 15,625 | -15.6% | 0.03% | -3.1% |
| Q1 2018 | $727,000 | -17.9% | 18,519 | -25.2% | 0.03% | -13.5% |
| Q4 2017 | $885,000 | -19.2% | 24,754 | -8.8% | 0.04% | -26.0% |
| Q3 2017 | $1,095,000 | -12.0% | 27,131 | -6.2% | 0.05% | -15.3% |
| Q2 2017 | $1,244,000 | -8.9% | 28,921 | -11.2% | 0.06% | -9.2% |
| Q1 2017 | $1,365,000 | +8.7% | 32,551 | +1.0% | 0.06% | 0.0% |
| Q4 2016 | $1,256,000 | -38.7% | 32,244 | -32.2% | 0.06% | -16.7% |
| Q3 2016 | $2,050,000 | +45.9% | 47,539 | +46.1% | 0.08% | -4.9% |
| Q2 2016 | $1,405,000 | +36.8% | 32,528 | +28.1% | 0.08% | +28.1% |
| Q1 2016 | $1,027,000 | -7.2% | 25,395 | -8.1% | 0.06% | -9.9% |
| Q4 2015 | $1,107,000 | +12.8% | 27,621 | +9.4% | 0.07% | +6.0% |
| Q3 2015 | $981,000 | -26.2% | 25,243 | -11.7% | 0.07% | -21.2% |
| Q2 2015 | $1,330,000 | 0.0% | 28,599 | 0.0% | 0.08% | 0.0% |
| Q1 2015 | $1,330,000 | +33.9% | 28,599 | +23.3% | 0.08% | +21.4% |
| Q4 2014 | $993,000 | +44.1% | 23,200 | +54.8% | 0.07% | +48.9% |
| Q3 2014 | $689,000 | -11.7% | 14,989 | +2.8% | 0.05% | -7.8% |
| Q2 2014 | $780,000 | +9.9% | 14,587 | +9.8% | 0.05% | 0.0% |
| Q1 2014 | $710,000 | +29.8% | 13,288 | +29.8% | 0.05% | +21.4% |
| Q4 2013 | $547,000 | +13.7% | 10,235 | +7.6% | 0.04% | 0.0% |
| Q3 2013 | $481,000 | +3.4% | 9,510 | +1.2% | 0.04% | -8.7% |
| Q2 2013 | $465,000 | +6.9% | 9,397 | +2.0% | 0.05% | +4.5% |
| Q1 2013 | $435,000 | – | 9,216 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |